Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonistF De Benedetti, P Pignatti, M Vivarelli, et al.
The Journal of Rheumatology|September 16, 2000
Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritisF De Benedetti, M Vivarelli, P Pignatti, et al.
Diabetes Research and Clinical Practice|January 1, 1993
CD5-positive B cells in type 1 (insulin-dependent) diabetic childrenR Lorini, M Massa, G d'Annunzio, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 15, 2013
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6A Del Fattore, A Cappariello, M Capulli, et al.
Clinical and Experimental Rheumatology|March 1, 1994
Anti-double stranded DNA, anti-histone, and anti-nucleosome IgG reactivities in children with systemic lupus erythematosusM Massa, F De Benedetti, P Pignatti, et al.
Annals of the Rheumatic Diseases|July 1, 1989
Variation of serum IgG subclass concentrations with disease activity in juvenile chronic arthritisA Martini, M A Avanzini, A Ravelli, et al.
British Journal of Rheumatology|May 1, 1997
Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritisF de Benedetti, P Pignatti, M Massa, et al.
American Journal of Hematology|July 1, 1994
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's diseaseV Perfetti, V Bellotti, A Maggi, et al.
Pageof 9